Overview

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Z-215 (10 mg, 20 mg, 40 mg) , compared with Rabeprazole Sodium 10mg in patients with erosive esophagitis of Grade A to D as defined by the LA classification grading system.
Phase:
Phase 2
Details
Lead Sponsor:
Zeria Pharmaceutical
Treatments:
Rabeprazole